Anorexia not just a psychiatric disorder, it is also metabolic

Summary: A large scale genome-wide study suggest the origins of anorexia include both metabolic and psychiatric components.

Source: University of North Carolina Health Care

A new large-scale genome-wide association study published in Nature Genetics, has identified eight genetic variants significantly associated with anorexia nervosa; and the research shows that the origins of this serious disorder appear to be both metabolic and psychiatric.

Anorexia nervosa is a life-impairing illness characterized by dangerously low body weight, an intense fear of gaining weight, and a lack of recognition of the seriousness of the low body weight. Anorexia nervosa has the highest mortality rate of any psychiatric illness, according to the National Center of Excellence for Eating Disorders.

“Until now, our focus has been on the psychological aspects of anorexia nervosa such as the patients’ drive for thinness. Our findings strongly encourage us to also shine the torch on the role of metabolism to help understand why individuals with anorexia frequently drop back to dangerously low weights, even after therapeutic renourishment. A failure to consider the role of metabolism may have contributed to the poor track record among health professionals in treating this illness,” said principal investigator Cynthia M. Bulik, PhD, FAED, founding director of the UNC Center of Excellence for Eating Disorders and Distinguished Professor in the Department of Psychiatry in the UNC School of Medicine.

This shows a tomato and measuring tape

The genetic basis of anorexia nervosa overlaps with other psychiatric disorders such as obsessive-compulsive disorder, depression, anxiety, and schizophrenia. The image is in the public domain.

For the study, Bulik and a multinational group of more than 100 researchers combined data collected by the Anorexia Nervosa Genetics Initiative (ANGI) and the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED). The resulting data set included 16,992 anorexia nervosa cases and 55,525 controls of European ancestry from 17 countries across North America, Europe, and Australasia.

Other findings of the study include:

  • The genetic basis of anorexia nervosa overlaps with other psychiatric disorders such as obsessive-compulsive disorder, depression, anxiety, and schizophrenia.
  • Genetic factors associated with anorexia nervosa also influence physical activity, which could help explain the tendency for people with anorexia nervosa to be highly active.
  • Intriguingly, the genetic basis of anorexia nervosa overlaps with metabolic (including glycemic), lipid (fats), and anthropometric (body measurement) traits, and the study shows that this is not due to genetic effects that influence BMI.

Dr. Gerome Breen of King’s College London, who co-led the study said, “Metabolic abnormalities seen in patients with anorexia nervosa are most often attributed to starvation, but this study shows they may also contribute to the development of the disorder. These results suggest that genetic studies of eating disorders may yield powerful new clues about their causes and may change how we approach and treat anorexia.”

The study concludes that anorexia nervosa may be a ‘metabo-psychiatric disorder’ and that it will be important to consider both metabolic and psychological risk factors when exploring new avenues for treating this potentially lethal illness.

Researchers from over 100 institutions worldwide participated in the study.

The Anorexia Nervosa Genetics Initiative (ANGI) is an initiative of The Klarman Family Foundation. ANGI was led by Dr. Bulik at the University of North Carolina at Chapel Hill with collaborators from Karolinska Institutet, Stockholm, Sweden (Dr. Mikael Landén), Aarhus University, Aarhus, Denmark (Dr. Preben Bo Mortensen), and Berghofer Queensland Institute for Medical Research, Brisbane, Australia (Dr. Nick Martin) with assistance from the University of Otago, Christchurch New Zealand (Drs. Martin Kennedy and Jenny Jordan). ANGI contributed 13,363 cases to the GWAS. Drs. Bulik and Breen co-chair the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED), which contributed the second largest number of samples and is expanding these studies to include other eating disorders as well.

Funding: Funding was provided by The Klarman Family Foundation, the U.S. National Institute of Mental Health, the UK National Institute for Health Research, and the Foundation of Hope, Raleigh, NC.

About this neuroscience research article

Source:
University of North Carolina Health Care
Media Contacts:
Carleigh Gabryel – University of North Carolina Health Care
Image Source:
The image is in the public domain.

Original Research: Open access
“Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa”. Cynthia M. Bulik et al.
Nature Genetics. doi:10.1038/s41588-019-0439-2

Abstract

Genome-wide association study identifies eight risk loci and implicates metabo-psychiatric origins for anorexia nervosa

Characterized primarily by a low body-mass index, anorexia nervosa is a complex and serious illness, affecting 0.9–4% of women and 0.3% of men with twin-based heritability estimates of 50–60%5. Mortality rates are higher than those in other psychiatric disorders, and outcomes are unacceptably poor. Here we combine data from the Anorexia Nervosa Genetics Initiative (ANGI) and the Eating Disorders Working Group of the Psychiatric Genomics Consortium (PGC-ED) and conduct a genome-wide association study of 16,992 cases of anorexia nervosa and 55,525 controls, identifying eight significant loci. The genetic architecture of anorexia nervosa mirrors its clinical presentation, showing significant genetic correlations with psychiatric disorders, physical activity, and metabolic (including glycemic), lipid and anthropometric traits, independent of the effects of common variants associated with body-mass index. These results further encourage a reconceptualization of anorexia nervosa as a metabo-psychiatric disorder. Elucidating the metabolic component is a critical direction for future research, and paying attention to both psychiatric and metabolic components may be key to improving outcomes.

Feel free to share this Genetics News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive the latest neuroscience headlines and summaries sent to your email daily from NeuroscienceNews.com
We hate spam and only use your email to contact you about newsletters. We do not sell email addresses. You can cancel your subscription any time.
No more articles